Finance

Lists
JANX:NASDAQ
Janux Therapeutics Inc
18,15 USD
-1,31%
(-0,24) 1D
18,15 USD
0,00% (0,00)
After hours
Closed: 12-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JANX...
Open
18,29 USD
High
18,60 USD
Low
17,96 USD
Mkt. cap
1,11 млд
Avg. vol.
972,62 миң
Volume
802,98 миң
52-wk high
35,25 USD
52-wk low
12,12 USD
EPS
-1,64 USD
Beta
2,40
Shares outstanding
61,14 млн
No. of employees
113
Open
18,29 USD
High
18,60 USD
Low
17,96 USD
Mkt. cap
1,11 млд
Avg. vol.
972,62 миң
Volume
802,98 миң
52-wk high
35,25 USD
52-wk low
12,12 USD
EPS
-1,64 USD
Beta
2,40
Shares outstanding
61,14 млн
No. of employees
113
News stories
From web sources and news partners
About Janux Therapeutics Inc
CEO-
Employees113
Founded2017
Headquarters-
Sector-
Analyst ratings
Based on 11 analysts giving stock ratings to JANX in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for JANX in the last 3 months.
Highest
Current 18,15 USD
60,00 USD (+230,58%)
Average
34,22 USD (+88,54%)
Lowest
14,00 USD (-22,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
45,00 USD
+147,9%
10/01/2026
Kalpit Patel
Wolfe Research
Buy
Upgraded
23,00 USD
+26,7%
08/24/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
08/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
35,00 USD
+92,8%
08/11/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
60,00 USD
+230,6%
08/07/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
-
-
08/07/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
26,00 USD
+43,3%
08/07/2026
Boris Peaker
JonesTrading
Buy
Maintained
28,00 USD
+54,3%
08/07/2026
Bradley Canino
Guggenheim
Buy
Reiterated
55,00 USD
+203%
08/06/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
22,00 USD
+21,2%
08/07/2026
Etzer Darout
Barclays
Sell
Maintained
14,00 USD
-22,9%
08/07/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
22,00 USD
+21,2%
05/11/2026
Robert Driscoll
Wedbush
Buy
Reiterated
36,00 USD
+98,3%
05/08/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/08/2026
Unknown Analyst
Wedbush
Buy
Reiterated
36,00 USD
+98,3%
05/08/2026
David Dai
UBS
Hold
Downgraded
15,00 USD
-17,4%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
50,00 USD
+175,5%
04/06/2026
Karina Rabayeva
Truist Financial
Buy
Reiterated
80,00 USD
+340,8%
03/03/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
100,00 USD
+451%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
10,00 млн
-
3,73 млн
10,27 млн
Cost of goods sold
34,63 млн
31,55 млн
26,81 млн
30,99 млн
Cost of revenue
34,63 млн
31,55 млн
26,81 млн
30,99 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,62 млн
10,85 млн
11,13 млн
10,96 млн
Operating expense
10,62 млн
10,85 млн
11,13 млн
10,96 млн
Total operating expenses
45,25 млн
42,40 млн
37,95 млн
41,96 млн
Operating income
-35,25 млн
-42,40 млн
-34,21 млн
-31,69 млн
Other non operating income
-
-
-
-
EBT including unusual items
-24,31 млн
-31,95 млн
-24,36 млн
-21,97 млн
EBT excluding unusual items
-24,31 млн
-31,95 млн
-24,36 млн
-21,97 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24,31 млн
-31,95 млн
-24,36 млн
-21,97 млн
Net profit margin
-243,13%
-
-652,59%
-214,01%
Earnings per share
-0,39
-0,51
-0,39
-0,35
Interest and investment income
10,94 млн
10,46 млн
9,85 млн
9,72 млн
Interest expense
-
-
-
-
Net interest expenses
10,94 млн
10,46 млн
9,85 млн
9,72 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-34,75 млн
-41,93 млн
-33,74 млн
-31,23 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору